* Renal insufficiencies
|
|
- Byron Fisher
- 5 years ago
- Views:
Transcription
1 Thrombotic Thrombocytopenic Purpura Behzad Poopak, DCLS PhD. Tehran medical Branch Islamic Azad university
2 Case Summary Ms. X, a 35-year year-old woman Complained of weakness, low grade fever, periods of forgetfulness, and memory loss for last week or so. Denied any viral/bacterial illness prior to onset of symptoms. +Oral contraceptives, but no other drugs. Large number of bruises on her extremities. As her condition worsen, she began to be afflicted with frequent seizures, headaches, and dizziness.
3 Key Information Pointing to Diagnosis Symptoms Low grade fever Periods of forgetfulness and memory loss Seizures, headaches, and dizziness Bruises on extremities Table 1: Laboratory Results Test Result Normal Range Hemoglobin 6.0 g/dl g/dl Hematocrit 0.18 L/L L/L White Blood Cells 8.9 x 10 9 /L x10 9 /L Platelet 31 x10 9 /L x10 9 /L Sinificant Laboratory Findings Peripheral Smear: Reticulocyte 2.5% Schistocytes and polychromasia Protein 2+ Table 2: Results of urinalysis Blood + * Renal insufficiencies
4 Significant lab results confirmed the presence of hematuria, decreased hemoglobin, and thrombocytopenia, but most importantly, the presence of Schistocytes. All of these findings are consistent with a hemolytic episode associated with: Micriangyophatic Hemolytic Anemia (MAHA). Diagnosis: MAHA
5 Epidemiology Suspected TTP-HUS HUS- 11cases/million/yr Idiopathic TTP-HUS- 4.5 cases/million/yr Severe ADAMTS13 deficiency- i 1.7 cases/million/yr Incidence rates were greater for women and African-Americans Americans Prior to plasma exchange, mortality rate was as high as 90%, now less than 20%
6 Classic Symptoms of TTP-HUS Microangiopathic hemolytic anemia (MAHA) Thrombocytopenia Acute renal insufficiency (more common in HUS) Neurologic abnormalities (more common in TTP) Fever * Only thrombocytopenia and MAHA without another apparent etiology are required to initiate plasma exchange for presumed TTP-HUS HUS.
7 Terminology TTP and HUS (hemolytic uremic syndrome) are both acute syndromes with abnormalities in multiple organ systems Although some studies appear to distinguish these two entities the presenting features are essentially the same in most adult patients. Furthermore, the pathologic changes are the same and so is the initial treatment.
8 Definitions and Diagnosis The Classic Pentad of TTP Microangiopathic hemolytic anemia Thrombocytopenia Renal insufficiency or abnormalities Neurologic abnormalities that can be fluctuating Fever Most common symptoms at presentation are nonspecific and include abdominal pain, nausea, vomiting and weakness.
9 TTP HUS NUMBER OF SUBJECTS Hemolytic Anemia Thrombocytopenia Neurologic changes Acute Renal Failure 2 98 Fever Reminder: Both are clinical diagnoses! Adapted from Veyradier, A, et al. Blood 2001; 98:
10 Major Causes of TTP-HUS Idiopathic: 37% Infection: 9% Drug-Associated: 13% HIV Cyclosporine Tacrolimus Mitomycin C Bleomycin and cisplatin Gemcitabine Quinine i Ticlopidine and clopidogrel Autoimmune Disease: 13% Scleroderma SLE APLA Streptococcus pneumoniae Pregnancy/Postpartum: 7% Bloody Diarrhea Prodrome: 6% Shiga toxin production (ex: E. coli 0157:H7) Shigella dysenteriae type 1 Verocytotoxin production by Citrobacter freundii Hematopoietic cell transplantation: 4%
11 Differential Diagnosis Vasculitis Malignant Hypertension DIC Antiphosphospholipid Syndrome
12 TTP: Current Diagnostic Criteria Thrombocytopenia Microangiopathic hemolytic anemia No alternative explanation
13 Definitions Continued MAHA-nonimmune hemolysis (negative DAT) with prominent red cell fragmentation ti (schistocytes schistocytes) t on peripheral blood smear. Will exhibit increased LDH and indirect bili. Schistocytes-in t in the appropriate clinical i l setting schistocyte count>1% was strongly suggestive of TTP- HUS, ie 2 or more schistos in microscopic field at 100x magnification. Thromoboctyopenia- mean in a series was 25,300 prior to treatment. Renal disease- due to renal thrombotic microangiopathy, which is usually associated with a UA that is often near normal with only mild proteinuria (between 1-2 g/day) and few cells or casts
14 Definitions Continued Neurologic symptoms - most are subtle, such as transient confusion or severe headache. Focal, objective abnormalities are less common, but grand mall seizures and coma can occur. Fever- less frequent finding, but the presence of chills and high spiking fever should suggest dx of sepsis or DIC. Cardiac involvement- incidence is difficult to determine, but diffuse platelet thrombi and associated dh hemorrhage h in cardiac tissues can lead to arrythmias, MIs, sudden death, shock, or heart failure.
15 Labs to Look For Schistocytes on peripheral smear Elevated LDH Decreased Haptoglobin Increased Creatinine Thrombocytopenia (more pronounced in TTP than HUS)
16 *Intravascular Hemolysis is also associated with the presence of Schistocytes Burr Cells Renal Disease Liver Disease Burns Morphology : Fragmented Cells Possible Pathology Schistocyte Helmet Cells Prosthetic Heart Valve Microangiopathic Hemolytic Anemia Clostridial Infections G6PD Deficiency Pulmonary Emboli Disseminated Intravascular Coagulation Thrombotic Thrombocytope nic Purpura Hemolytic Uremic Syndrome Microangiopathic Hemolytic Anemia (MAHA)
17 SCHISTOCYTES!
18 Schistocytes-TTP
19 HUS-Diagnosis Diarrhoea (often bloody) Haematological microangiopathic haemolytic anaemia thrombocytopenia Fragmented red cells Absence of platelets
20 ADAMTS13 (Another Lab to Order) A Disintegrin-like And Metalloprotease with ThromboSpondin type 1 repeats Mapped the gene for the metalloprotease to chromosome 9q34 with linkage analysis Protease that cleaves ULVWf (Unusually Large Von Willebrand factor) in the circulation Decreased activity or inhibitor present in TTP, but not HUS Identified 12 mutations in patients with hereditary TTP clinical picture
21 VWF Cleaving Protease (ADAMTS13) Metalloprotease Thrombospondin 1 S P M D 1 Cys Spacer CUB CUB Disintegrin ADisintegrin-like And Metalloprotease with ThromboSpondin-1 repeats (#13 among 19 total)
22 ADAMTS13 30 pts psdag diagnosed d with TTP: 6 pts. with familial TTP lacked all ADAMTS13 activity 24 pts. with nonfamilial l TTP 20 had severe deficiency (<5% of normal activity) 4 had moderate deficiency y( (5-25% of nml activity) 23 pts diagnosed with HUS: 21 pts. with normal activity Furlan, M, et al. Von Willebrand factor-cleaving cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. NEJM 1998; 339:
23 Pathogenesis VWF is synthesized in endothelial cells and assembled in large multimers that are present in normal plasma. The large multimers, ie unusually large von willebrand factor (ULVWF) are rapidly degraded in the circulation into normal size range of VWF multimers by ADAMTS ADAMTS13 deficiency could lead to accumulation of ULVWF multimers, platelet aggregation, and platelet clumping. ULVWF multimers accumulate in patients with TTP being found in platelet thrombi and serum. The ULVWF can attach to activated platelets thereby promoting aggregation.
24 Figure 1. Pathogenesis of idiopathic thrombotic thrombocytopenic purpura (TTP) caused by ADAMTS13 deficiency Sadler, J. E. Hematology 2006;2006: Copyright 2006 American Society of Hematology. Copyright restrictions may apply.
25 Von Willebrand Factor Cleaving Protease, vwf, and Platelets Under Normal Conditions vwf-cleaving protease (ADAMTS13) Tyr-Met AA bond in vwf Receptor for GP Ib on the platelets Platelet
26 vwf and Platelets When Von Willebrand Factor Cleaving Protease is Absent or Deficient
27 vwf and Platelets When Von Willebrand Factor Cleaving Protease is Absent or Deficient, Cont.
28 VWF, ADAMTS13 and Platelet Adhesion With ADAMTS13 Without ADAMTS13 Normal VWF Multimers Normal Hemostasis Ultralarge VWF Multimers Microvascular Thrombosis (TTP)
29 TTP TTP can be categorized into 2 major forms: Hereditary: Often seen in children, and caused by mutations of ADAMTS13 gene Acquired: Mainly seen in adults, may be idiopathic or nonidiopathic. Idiopathic: results from autoantibodies that inhibit ADAMTS13 function Nonidopathic: TTP is secondary to other conditions such as hematopoeitic stem cell transplantation, certain drugs, infections, other autoimmune diseases, cancers, and so on.
30 ADAMTS13 Clinical Correlations ADAMTS13 deficiency y( (<5%)predicts: Idiopathic TTP Complete response to plasma exchange Survival ADAMTS13 inhibitor predicts: Prolonged time to complete response Death Relapse Reviewed in Coppo et al, Br J Haematol 2005; 132: 66-74
31 The Oklahoma TTP-HUS Registry ADAMTS13 measured di immediately before beginning the first plasma exchange, November 13, 1995 December 31, patients with 1 st episode of TTP ADAMTS13 measured in 261 (93%) Measurements (immunoblot immunoblot, FRETS)
32 The Oklahoma TTP-HUS Registry ADAMTS13 Activity <10 10% Stem cell transplant 1/1010 (10%) Pregnant/postpartum 3/15 (21%) Drug-associated 0/35 (0%) Bloody diarrhea 2/22 22 (10 10%) Additional/alternative diagnosis autoimmune diseases 3/3131 (10%) sepsis 4/22 (18 18%) malignancy 1/1010 (10%) other disorders 0/18 (0%) Idiopathic 46/98 (47%)
33 The Oklahoma TTP-HUS Registry 60 Consecutive Patients with Severe ADAMTS13 Deficiency (<10 10% activity) Age 41 years ( ) Sex 49 (82 82%) female Race 21 (35%) black
34 The Oklahoma TTP-HUS Registry ADAMTS13 Deficiency (<10 10% activity) Neurologic abnormalities severe 30 (50%) mild 13 (22%) none 17 (28 28%) Renal function acute renal failure 6 (10 10%) renal insufficiency 27 (45%) normal 27 (55%) Fever 13 (22%) Complete Pentad 5 (8%)
35 ADAMTS13 An inhibitory autoantibody t to ADAMTS13 has been found at varying titers among high percentage of patients with idiopathic TTP who have severe ADAMTS13 deficiency, and the inhibitory IgG is directed at various elements of the protease. It has been suggested that levels of ADAMTS13 less than 5% with or without an inhibitor antibody may be part of a larger autoimmune response. Non-inhibitory antibodies to ADAMTS13 have also been demonstrated.
36 ADAMTS13 and prognosis So usually, in acute idiopathic TTP, there is a severe deficiency in ADAMTS13 activity (undetectable or <5%), although senstivity/specificity remains controversial. Severe deficiency is less common in secondary TTP. For most patients, a complete response to plasma exchange is accompanied by normalization of ADAMTS13 activity and disappearance of inhibitors, if present. Persistently undetectable ADAMTS13 in plasma during remission was found to be highly predictive of recurrence, and also the higher the antibody titers, clinical manifestations were more severe and responses to plasma exchange were delayed
37 Plasma Exchange Corticosteroids RITUXIMAB Treatment Humanized monoclonal l antibody against CD20 20, which is expressed on B cells, and it rapidly clears B cells from circulation, preventing replenishment of pathological plasma cells. Remission associated with disappearance of ADAMTS13 inhibitors and normalization of activity levels Should be considered in TTP patients who fail to respond to daily PE and corticosteroids after 7-14 days
38 Conclusions: Evaluation Forget the Classic Pentad of clinical features of TTP ADAMTS13 measurements: Limited diagnostic value Important p prognostic value
39 Conclusions: Management Plasma exchange remains essential treatment, but it has risks of death and major complications Appropriate use of platelet l t transfusions is appropriate
40 Conclusions: Long-Term Outcomes Relapse occurs in almost half of patients with ADAMTS13 <10% Risk of future pregnancies is small Risk of additional autoimmune disorders may be increased Neurocognitive abnormalities are common
41
42 References NEJM 2006; 354: George, James MD-Thrombotic Thrombocytopenic Purpura. Uptodate. Diagnosis, Causes, and Treatment of TTP-HUS Hematology 2004: Recent Advances in Thrombotic Thrombocyotopenic Purpura, Sadler Et al Hematology TTP and ADAMTS13: When is testing appropriate? Mannucci et al Hematology 2006.Thrombocytopenic Purpura:A moving Target. Sadler Hoffman:Hematology: Basic Principles and Practice fourth edition. Chapters 42 and 132 Swiss Med Wkly 2007; : Rituximab for acute plasma refractory thrombotic thrombocyotopenic purpura. Eur J Haematology 2005;75 75: Acquired TTP as presenting symptom of SLE. Successful treatment with plasma exchange and immunosuppression-report report of 2 cases Blood cells, Molecules and Diseases (2002) 28(3) May/June: Ritux Therapy for Refractory TTP Thrombotic Thrombocytopenic Purpura and Systemic Lupus Erythematous:Distinct entities or overlapping syndromes. Internet Journal of Internal Medicine; Cheung
Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13
Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists
More informationDR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL
DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL Rare but fatal disease if unrecognized and untreated Incidence about 1: 1 million in the USA Female preponderance of 2:1 Part
More informationWhat is meant by Thrombotic Microangiopathy (TMA)?
What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its
More informationBeyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura
Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Kristen Knoph, PharmD, BCPS PGY2 Pharmacotherapy Resident Pharmacy Grand Rounds April 25, 2017 2016 MFMER slide-1 Objectives
More informationSara K. Vesely, James N. George, Bernhard Lämmle, Jan-Dirk Studt, Lorenzo Alberio, Mayez A. El-Harake, and Gary E. Raskob
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS ADAMTS13 activity in thrombotic thrombocytopenic purpura hemolytic uremic syndrome: relation to presenting features and clinical outcomes in
More informationThrombotic Thrombocytopenic
The Treatment of TTP and the Prevention of Relapses GERALD APPEL, MD Professor of Clinical Medicine Columbia University College of Physicians and Surgeons NY-Presbyterian Hospital New York, New York Thrombotic
More informationDRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)
Preamble: A confirmed diagnosis of atypical hemolytic uremic syndrome (ahus) is required for eculizumab funding. The information below is to provide clinicians with context for how a diagnosis of ahus
More informationTHROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11
THROMBOTIC MICROANGIOPATHY Jun-Ki Park 7/19/11 TMAs are microvascular occlusive disorders characterized by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes.
More informationHemolytic uremic syndrome: Investigations and management
Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;
More informationThrombotic thrombocytopenic purpura: a look at the future
Thrombotic thrombocytopenic purpura: a look at the future Andrea Artoni, MD Ph.D. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS Ca Granda Ospedale Maggiore Policlinico Milan, Italy andrea.artoni@policlinico.mi.it
More informationLet`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016
Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Case report 20 months old girl Israeli Arab Muslim family, consanguineous marriage
More informationObjectives. Thrombotic Thrombocytopenic Purpura (TTP) and ADAMTS13 Testing. Disclosure
Thrombotic Thrombocytopenic Purpura (TTP) and Testing Dong Chen MD PhD Special Coagulation Laboratory Mayo Clinic-Rochester 2018 Disclosure Chair, CAP Coagulation Resource Committee Mayo Medical Laboratory
More informationAtypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature
Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Mouhanna Abu Ghanimeh 1, Omar Abughanimeh 1, Ayman Qasrawi 1, Abdulraheem
More informationApproccio morfologico alle microangiopatie trombotiche
Approccio morfologico alle microangiopatie trombotiche Gina Zini Polo Oncologia e Ematologia Policlinico A. Gemelli Università Cattolica S. Cuore - Roma 1 Thrombotic microangiopathies Occlusive microangiopathic
More informationRenal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist
Renal failure and thrombocytopaenia? Don t forget TTP/HUS Jonathan Wala Nephrologist Thrombotic microangiopathies Disorders characterized by: thrombocytopaenia microangiopathic haemolytic anaemia (MAHA)
More informationThrombotic thrombocytopenic purpura: 2008 Update
MEDICAL GRAND ROUNDS CME CREDIT MARK A. CROWTHER, MD Director, Division of Hematology, McMaster University, Hamilton, Ontario, Canada JAMES N. GEORGE, MD Hematology-Oncology Section, Department of Medicine,
More informationNew insights in thrombotic microangiopathies : TTP and ahus
New insights in thrombotic microangiopathies : TTP and ahus Dr Catherine LAMBERT Hematology Cliniques universitaires Saint-Luc Catherine.lambert@uclouvain.be New insights in thrombotic microangiopathies
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationLAMA SHATAT TTP, ITP, DIC
TTP, ITP, DIC Reduction in platelet number (thrombocytopenia) constitutes an important cause of generalized bleeding. A count less than 100,000 platelets/μl is generally considered to constitute thrombocytopenia.
More informationA 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch
A 60 year old woman with altered mental status and thrombotic microangiopathy Josh Veatch Previously healthy 60 year old woman 2 3 months of fatigue following a URI, transient episodes being out of it
More informationSome renal vascular disorders
Some renal vascular disorders Introduction Nearly all diseases of the kidney involve the renal blood vessels secondarily We will discuss: -Hypertension (arterionephrosclerosis in benign HTN & hyperplastic
More informationThings to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC
Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial
More informationThrombotic Microangiopathies
Thrombotic Microangiopathies ASH/San Antonio Breast Cancer Symposium Review James N. George March 14, 2015 Thrombotic Microangiopathies (TMA): Everything you need to know from 5 patient stories Thrombotic
More informationTMA in HUS and TTP: new insights
TMA in HUS and TTP: new insights Daan Dierickx University Hospitals Leuven, Department of Hematology, Belgium 20th Annual Meeting Belgian Society on Thrombosis and Haemostatis Antwerpen, 22 th November
More informationNon-immune acquired haemolytic anaemias. Dr.Maysem
Non-immune acquired haemolytic anaemias Dr.Maysem Causes of Non-immune acquired haemolytic anaemias. Infections Infections can cause haemolysis in a variety of ways: -They may precipitate an acute haemolytic
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationPathology note 8 BLEEDING DISORDER
Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more
More informationBleeding and Thrombotic Disorders. Kristine Krafts, M.D.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden
More informationHUS and TTP Testing. Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI
HUS and TTP Testing Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI Disclosures Relevant Financial Relationships Consultant: Ablynx, Bayer, CSL Behring,
More informationMost Common Hemostasis Consults: Thrombocytopenia
Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial
More informationClinical study of 9 patients with acquired thrombotic thrombocytopenic purpura
Journal of Clinical and Experimental Medicine VOL.1,ISS.3,DEC 2017,1-5 ONLINE ISSN: 2523-2835 www.jocem.org PRINT ISSN: 2521-0084 DOI:10.29422/jocem.2017.03.001 Abstract: Clinical study of 9 patients with
More informationDr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College
Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction
More informationISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CENTRO MARIO DI NEGRI RICERCHE INSTITUTE CLINICHE FOR PHARMACOLOGICAL PER LE MALATTIE RESEARCH RARE CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES
More informationPresentation Outline. Disease Background Previous research on platelet recovery rate Goal of our study Methods Results Limitations Conclusions
Platelet Recovery Rate at Day 5 of Therapeutic Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura Can Aid in Identifying Risk of Disease Exacerbation Suzanne Zhou, Yara A. Park, Marian A.
More informationR. Coward has documented that he has received cooperative grants from Takeda and Novo Nordisk
R. Coward has documented that he has received cooperative grants from Takeda and Novo Nordisk Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy Lindsay Keir Richard
More informationPlatelets: Thrombotic Thrombocytopenic Purpura
Platelets: Thrombotic Thrombocytopenic Purpura James N. George, J. Evan Sadler, and Bernhard Lämmle Abnormalities of plasma von Willebrand factor (VWF) have been recognized to be associated with thrombotic
More informationTTP and ADAMTS13: When Is Testing Appropriate?
TTP and ADAMTS13: When Is Testing Appropriate? Pier Mannuccio Mannucci and Flora Peyvandi A. Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Medicine and Medical Specialities, University
More information1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia),
Ravi Sarode, MD Consensus Process The TTP-CC subcommittee developed 7 key questions Sent to the 7 speakers for electronic voting in Yes or No format Will be published in JCA soon Q.1 Untreated TTP carries
More informationHeme (Bleeding and Coagulopathies) in the ICU
Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related
More informationSoliris (eculizumab) DRUG.00050
Market DC Soliris (eculizumab) DRUG.00050 Override(s) Prior Authorization Approval Duration 1 year Medications Soliris (eculizumab) APPROVAL CRITERIA Paroxysmal Nocturnal Hemoglobinuria I. Initiation of
More informationBehzad Poopak, DCLS PhD
Behzad Poopak, DCLS PhD Test Report Name Age Critical Low HEMATOLOGY Activated Partial Thromboplastin Time, Plasma Critical High - 150 sec Units Fibrinogen 60 - mg/dl INR (International Normalizing
More informationThrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular. Genetics
Thrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular Genetics Helen Liapis, M.D. Senior Consultant Arkana Labs Professor of Pathology & Immunology. retired Washington University School
More informationSymposium. Acute Kidney Injury with Thrombocytopenia. Lalitha A V*, Suryanarayana G**, Sumithra S***
Symposium Acute Kidney Injury with Thrombocytopenia 10.21304/2018.0502.00372 Lalitha A V*, Suryanarayana G**, Sumithra S*** *Associate Professor, Head,PICU **, Fellow in PICU, *** Assistant Professor,
More informationAnemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi
Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH
More informationAnemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh
Anemia (3).ms4.26.2.18 Hemolytic Anemia Abdallah Abbadi Feras Fararjeh Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k,
More informationAABB 2003 ANNUAL MEETING AWARD LECTURES
Blackwell Science, LtdOxford, UKTRFTransfusion0041-11322004 American Association of Blood BanksSeptember 200444913841392Original ArticleTHE OKLAHOMA TTP-HUS REGISTRYGEORGE AABB 2003 ANNUAL MEETING AWARD
More informationBleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD
Bleeding Disorders.2 MS4.25.02.2019 Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD Email: abdalla.awidi@gmail.com Case 6: GT 18 yr old female was admitted with pallor, abdominal pain and gum
More informationA Rational Approach to Evaluation of Thrombotic Microangiopathy
A Rational Approach to Evaluation of Thrombotic Microangiopathy An Algorithmic Approach C. Christopher Hook, MD for the Complement Alternative Pathway Thrombotic Micro- Angiopathy (CAP-TMA) Disease-Oriented
More informationA 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis).
A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis). He was found to have severe kidney injury requiring
More informationAswanth P. Reddy, Ujjwal Gupta, and Jonathan S. Harrison. University of Connecticut, Farmington, Connecticut, USA
CASE REPORT Rituximab in Relapsing acquired Thrombotic Thrombo cytopenic Purpura: Experience and Evidence 1 2 1* Aswanth P. Reddy, Ujjwal Gupta, and Jonathan S. Harrison 1 University of Connecticut, Farmington,
More informationThe Bleeding Patient. Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand
The Bleeding Patient Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand The Bleeding Patient If you prick us, do we not bleed? Disorders of secondary homeostasis: dysfunction
More informationPaolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia
Le sindromi trombotiche microangiopatiche: il ruolo del laboratorio Paolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia Microangiopatie trombotiche:
More informationHemostatic System - general information
PLATELET DISORDERS Hemostatic System - general information Normal hemostatic system vessel wall circulating blood platelets blood coagulation and fibrynolysis Bleeding Diathesis inherited or acquired defects
More informationResults of the TITAN study for Caplacizumab
Results of the TITAN study for Webcast presentation 17th June 2014 Nanobodies - Inspired by nature Forward looking statements Certain statements, beliefs and opinions in this presentation are forward-looking,
More informationPrimary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes:
General department INTRODUCTION The hemolytic uremic syndrome (HUS): microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury One of the main causes of acute kidney injury in children
More informationDepartment of Clinical Haematology. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP): Summary
Diagnosis and management of thrombotic thrombocytopenic purpura (TTP): Summary Suspected TTP Investigations Further Investigations Blood Products URGENT treatment Suspect TTP if MAHA and thrombocytopenia
More informationThe utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
research paper The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry Sevda Hassan, 1 John-Paul Westwood, 2 Debra Ellis, 2 Chris
More informationDocument Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012
Project: Ghana Emergency Medicine Collaborative Document Title: Hemostasis: Platelet and Coagulation Disorders Author(s): Joseph H. Hartmann (University of Michigan), DO 2012 License: Unless otherwise
More informationEDUCATIONAL COMMENTARY PLATELET DISORDERS
EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20119 holds various files of this Leiden University dissertation. Author: Lotta, Luca Andrea Title: Pathophysiology of thrombotic thrombocytopenic purpura
More informationOncologic Emergencies. Angelina The, MD Lynn Cancer Institute August 30, 2016
Oncologic Emergencies { Angelina The, MD Lynn Cancer Institute August 30, 2016 What constitutes an oncologic emergency? Complications arising from Cancer Paraneoplastic syndrome Treatment of cancer Requires
More information1. INSTRUCTIONS 2. DEFINITION OF HUS
CQ_IBK_aHUS_01 / version 25/11/09 European Paediatric Research Group for HUS and related disorders Case questionnaire for diarrhoea negative/vtec (STEC) negative cases acute phase 1. INSTRUCTIONS Please
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
More informationThrombotic Thrombocytopenic Purpura and ADAMTS-13: New Insights into Pathogenesis, Diagnosis, and Therapy
Thrombotic Thrombocytopenic Purpura and ADAMTS-13: New Insights into Pathogenesis, Diagnosis, and Therapy Janis Wyrick-Glatzel, MS, MT(ASCP) (University of Nevada Las Vegas, Las Vegas, NV) DOI: 10.1309/77KRKLJW0EA75T2R
More informationPLASMA EXCHANGE J MANION NEPEAN HOSPITAL
PLASMA EXCHANGE J MANION NEPEAN HOSPITAL PLASMA The fluid portion of blood Normally approx 5% body weight or 3.5L in 70kg male Clots on standing unless anticoagulated Common plasma proteins are albumin,
More informationYear 2004 Paper one: Questions supplied by Megan
QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin
More informationNot So Benign Hematology Aplastic anemia, Paroxysmal Nocturnal Hemoglobinuria, atypical Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura
Not So Benign Hematology Aplastic anemia, Paroxysmal Nocturnal Hemoglobinuria, atypical Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura Robert A. Brodsky, MD Johns Hopkins Family Professor
More informationA 36 year old previously healthy female develops fever and ruising
Renal vascular diseases CPC G.A. Appel MD M.B. Stokes MD Case 1 A 36 year old previously healthy female develops fever and bruising. She goes to her LMD and CBC shows plats 15 K, Hct 28%, normal PT and
More informationDr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL
Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL CASE HISTORY 4 yrs old previously well boy Born to 2 nd degree consanguinity Fever x 5 days
More informationFor platelet control as individual as you
For platelet control as individual as you Explore the possibilities of Immune Thrombocytopenic Purpura (ITP) treatment. Important Risk Information WARNING: INTRAVASCULAR HEMOLYSIS (IVH) Intravascular hemolysis
More information3 Ruba hussein Dr. ahmad Dr. ahmad
3 Ruba hussein Dr. ahmad Dr. ahmad The arrangement of this sheet differs from that of the record. Anemia of peripheral removal in which we are losing hemoglobin and RBCs mass and the two major Causes are:
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury
More informationAcute Immune Thrombocytopenic Purpura (ITP) in Childhood
Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Guideline developed by Robert Saylors, MD, in collaboration with the ANGELS team. Last reviewed by Robert Saylors, MD September 22, 2016. Key Points
More informationAcquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan Masanori Matsumoto 1, Charles L. Bennett 2, Ayami Isonishi 1, Zaina Qureshi 2, Yuji Hori 1,
More informationCase report 24 th Summer School of Internal Medicine 2015
Case report 24 th Summer School of Internal Medicine 2015 Goldmannová D., Horák P., Skácelová M. IIIrd Internal Clinic - endocrinology, diabetology, rheumatology, nephrology University hospital Olomouc,
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Lapeyraque A-L, Malina M, Fremeaux-Bacchi V, et al. Eculizumab
More informationSpecialised Services Policy: CP98 Eculizumab for Atypical Haemolytic Uraemic Syndrome (ahus)
Specialised Services Policy: CP98 Eculizumab for Atypical Haemolytic Uraemic Syndrome (ahus) Document Author: Assistant Director for Evidence, Evaluation and Effectiveness Executive Lead: Medical Director
More informationHematologic changes in systemic diseases. Chittima Sirijerachai
Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:
More informationThrombotic thrombocytopenic purpura
The Intensive Care Society 2011 Thrombotic thrombocytopenic purpura J Thachil Thrombocytopenia is the most common coagulation problem in intensive care units with an incidence of up to 60% in some studies.
More informationDairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009
HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 WHEN BY THEN Hb 9 g% transfusion
More informationCase Report Ciprofloxacin-Induced Thrombotic Thrombocytopenic Purpura: A Case of Successful Treatment and Review of the Literature
Case Reports in Critical Care Volume 2015, Article ID 143832, 4 pages http://dx.doi.org/10.1155/2015/143832 Case Report Ciprofloxacin-Induced Thrombotic Thrombocytopenic Purpura: A Case of Successful Treatment
More informationFatal Thrombotic Throbmocytopenic Purpura Coexisting with Bacterial Infection: A Case Report
42 Fatal Thrombotic Throbmocytopenic Purpura Coexisting with Bacterial Infection: A Case Report Chih-Yuan Lin and Sheng-Huang Lin Abstract- Thrombotic thrombocytopenic purpura (TTP) has a varied clinical
More informationClinical Presentation and Follow-up of Eighteen Patients with Thrombotic Thrombocytopenic Purpura Received in: March 2007 Accepted in: 14/1/2010
Clinical Presentation and Follow-up of Eighteen Patients with Thrombotic Thrombocytopenic Purpura Received in: March 2007 Accepted in: 14/1/2010 Dr. Ahmed Khudair Yaseen Elmeshhedany * Dr. Ahmed Abdulmajeed
More informationSchematic Of Heparin Induced Thrombocytopenia Platelet Count
Schematic Of Heparin Induced Thrombocytopenia Platelet Count Normal IgG and IgG2 differentially inhibit HIT antibody-dependent platelet activation that platelet counts were lower in FcγRIIA 131RR patients
More informationCase Studies. Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade. Patient 1
Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade Emily Keeler, DO, 1* Gloria Fioravanti, DO, FACP, 1 Bensson Samuel, MD, PG Dip, 1 Santo Longo, MD 2 Lab Med
More informationUnusual association of lupus and thrombotic thrombocytopenic purpura like syndrome: clinical experience of a rare presentation
Abdellatif et al. J Unexplored Med Data 2018;3:5 DOI: 10.20517/2572-8180.2017.26 Journal of Unexplored Medical Data Case Report Open Access Unusual association of lupus and thrombotic thrombocytopenic
More informationThrombocytopenia: a practial approach
Thrombocytopenia: a practial approach Dr. med. Jeroen Goede FMH Innere Medizin, Medizinische Onkologie, Hämatologie FAMH Hämatologie Chefarzt Hämatologie Kantonsspital Winterthur Outline Introduction and
More informationKeeping track of your numbers
Keeping track of your numbers If you have relapsed or refractory multiple myeloma, keeping track of your numbers can help you take an active role in your care. It s also one way you and your doctor can
More informationThrombotic Microangiopathy in the era of HIV
Thrombotic Microangiopathy in the era of HIV Malcolm Davies A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, in partial fulfilment of the requirements
More informationmonoclonal gammopathy of undetermin Citation Rheumatology international, 33(1),
NAOSITE: Nagasaki University's Ac Title Author(s) Renal thrombotic microangiopathies/ in a patient with primary Sjögren's monoclonal gammopathy of undetermin Koga, Tomohiro; Yamasaki, Satoshi; Atsushi;
More informationINHERITED COAGULOPATHY
Disorder Etiology Pathophysiology and Presentation Lab Findings and Diagnosis Treatment INHERITED COAGULOPATHY HEMOPHILIA A and B Hemophilia A: deficiency in XIII (85%) Hemophilia B: deficiency in IX (15%)
More informationCase Report ISSN:
Case Report ISSN: 2581-6756 N-Acetylcysteine for Refractory Acquired Thrombotic Thrombocytopenic Purpura: New Dosage Approaches Ignacio Español 1, Juan Diego Leal 1, José Ros 2, José Sanmartín 2, María
More informationDoes Morphology Matter in 2017
Does Morphology Matter in 2017 ISLH May 2017 Kathryn Foucar Distinguished Professor Emerita kfoucar@salud.unm.edu Objectives Recognize unique RBC and WBC abnormalities in non-neoplastic disorders Learn
More informationAnemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017
Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.
More informationThe importance of thrombocytopenia and its causes
SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NO 4 2017 SEED HAEMATOLOGY The importance of thrombocytopenia and its causes Key words: Thrombocytopenia, thrombocytopenic, low levels of platelets What is
More informationClinical Study Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome
Hindawi Publishing Corporation Advances in Hematology Volume 214, Article ID 295323, 7 pages http://dx.doi.org/1.1155/214/295323 Clinical Study Therapy Leads to Rapid Resolution of Thrombocytopenia in
More informationDr. Apoorva Jayarangaiah MARSHFIELD CLINIC- Saint Joseph s Hospital
Dr. Apoorva Jayarangaiah MARSHFIELD CLINIC- Saint Joseph s Hospital A 30 year old G1P0 female of Korean descent was referred by her OBGYN during her 2 nd trimester to the Hematology Clinic for evaluation
More informationPeripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital
1395 Peripheral Blood Smear Examination Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital Peripheral Blood Smear A peripheral blood smear is a snapshot of the cells that are present
More informationOncologist. The. Thrombotic Thrombocytopenic Purpura Associated with Bone Marrow Metastasis and Secondary Myelofibrosis in Cancer
The Oncologist Thrombotic Thrombocytopenic Purpura Associated with Bone Marrow Metastasis and Secondary Myelofibrosis in Cancer JAE C. CHANG, a TAHIR NAQVI b a University of California, Irvine College
More information